Gene expression in triple-negative breast cancer in relation to survival.
Shuyang WangAlicia Beeghly-FadielQiuyin CaiHui CaiXingyi GuoLiang ShiJie WuFei YeQingchao QiuYing ZhengWei ZhengPing-Ping BaoXiao-Ou ShuPublished in: Breast cancer research and treatment (2018)
We identified five genes (EOMES, FA2H, GSPT1, RASGRP1, and SOD2) that may serve as potential prognostic biomarkers and/or therapeutic targets for TNBC.